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the disease in a rural Japanese population. We have performed
the survey in Matsudai town Niigara city, Japan since 1979 and
the survey was performed every 7 years. In this survey, check-
up included an interview, physical examination, anteroposterior
standing radiographs of both knees. In this survey, knee OA was
deﬁned as being present in a knee if radiographic grade of 2 or
higher with Kellegren and Lawrence (KL) scale were detected. In
current study, subjects were female ages were between 60 and 80
years who attended the both 4th (2000) and 5th (2007) project of
the Matsudai knee OA survey. In 5th survey, we measured urinary
N-terminal crosslinking telopeptide of type I collagen (NTx) and C-
terminal crosslinking telopeptide of collagen type II (CTX-II) of 564
female aged 60 and older. Occurrence of knee OA was deﬁned if
a grade 0 or 1 at the 4th survey advanced to grade 2 or higher
at 5th servay. Progression of the disease was deﬁned if a grade 2
at the fourth survey advanced to grade 3 or higher at 5th survey.
We compared the data of NTx and CTX-II between occurrence
and non-occurrence groups as well as between progression and
non-progression groups in age ranged 60-70 year-old and 71-
80 year-old. Statistical signiﬁcance of a difference between two
continuous variables tested by Mann-Whitney U test and a p-value
of less than 0.05 was considered statistically signiﬁcant.
Results: In younger participants, ages between 60 to 70 years,
showed the mean value of CTX-II in non-occurrence and
occurrence group were 231±212 (ng/mmolCr) and 315±255
(ng/mmolCr), respectively. The mean value of CTX-II in non-
progressive OA and progressive OA were 276±246 (ng/mmolCr)
and 416±314 (ng/mmolCr). We found occurrence and progression
group showed signiﬁcantly higher value of CTX-II in comparison
non-incident or non-progression groups (47% and 50% increase,
respectively) in aged between 60 to 70-year-old. In younger partic-
ipants, incident group and progression group were higher amount
of NTX than non- occurrence and progression group, but they
are not statistically signiﬁcant. People older than 71, there is no
statistically signiﬁcant difference in the value of CTX-II as well
as NTx between incident and non-incident as well as between
progression and non-progression groups.
Conclusions: Currently, there are no available biomarkers which
predict the disease progression of knee OA. Current study sug-
gested that CTX-II might be a candidate as an OA incident as well
as progression marker especially relatively younger female (60-70
years old) in this retrospective study of Matsudai knee OA survey.
124
IDENTIFICATION OF NOVEL BIOLOGICAL MARKERS OF
OSTEOARTHRITIS BY A PROTEOMIC APPROACH
M. Gharbi1, M. Deberg1, J.-E. Dubuc2, E. De Pauw1,
Y. Henrotin1
1Univ. of Liege, Liege, Belgium; 2Cliniques universitaires St-Luc,
Bruxelles, Belgium
Purpose: A proteomic approach was applied to discover novel
osteoarthritis speciﬁc biological markers by comparing the pro-
tein proﬁle of urines from healthy subjects (C), or patients with
osteoarthritis (OA) or osteoporosis (OP).
Methods: Urine samples were collected from 10 women (76±5
years) undergoing knee replacement surgery due to severe OA,
four age-matched women with severe osteoporosis (OP) and ﬁve
young healthy women (C) (25.6±2.6 years) without clinical signs
of joint disorders. Proteins were separated by two-dimensional
difference gel electrophoresis (2D-DIGE), and the proteins with
signiﬁcantly increased or decreased expression in the OA sample
were subject to identiﬁcation by tandem mass spectrometry.
Results: 19 spots intensity was increased or decreased at least
1.5 times in OA compared to C urine samples (t-test: p < 0.05).
Fibulin-3 (Q12805), Zn-α2 glycoprotein precursor (P25311), apop-
tosis factor 2 (Q9BRQ8), beta-actin (P60709), AMBP protein
precursor (P02760), GP36b glycoprotein (Q12907), polymeric-
immunoglobulin receptor (P01833) were found to be increased in
OA while serpin B1 (P30740), serpin B3 (P29508), kininogen-1
precursor (P01042), alpha 1 anti-trypsin (P01009), serotransfer-
rin (P02787), mannose binding lectin associated serine protease
(O00187) decreased in OA patients compared to C. Particularly,
ﬁve spots containing ﬁbulin-3 sequences were increased (by 4 to 8
fold according the isoform) in urine of patients with OA compared
with those of C, but decreased (by 4 to 12 fold according the
isoform) in OP urine compared with OA.
Conclusions: Some of the proteins identiﬁed are known to be
implicated in the inﬂammatory process, for example, the kinino-
gen precursor or alpha-1-antitrypsin. This observation coincides
with the pathology of osteoarthritis. A signiﬁcant increase in the
concentration of speciﬁc ﬁbulin-3 fragments was observed in OA
subjects compared to C and OP subjects. Functional classiﬁcation
indicates that ﬁbulin-3 is related with skeletal development and
its regulation by the interaction with some inhibitors of metallo-
proteases. These data suggest that ﬁbulin-3 fragments could be
useful biomarkers of OA.
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Purpose: The temporal relationship between OA changes in dif-
ferent structures and the clinical symptoms are not understood.
Image biomarkers that indicate preclinical disease or predict its
symptomatic stage would have signiﬁcant impact on the develop-
ment of disease prevention. We investigated feasibility of a fully-
automated quantitative analysis method and used the CiPAS©
software (José G Tamez-Peña, Monterrey, México) to segment
and analyze bones, cartilage and anatomic regions from knee MR
image data. Previous work showed that this method is repeatable
and highly reproducible for regions’ and structures’ signal intensity
measurements. In this study we compared the signal contrast at
the bone-cartilage interface in the central regions of the medial
and lateral compartments and the trochlea in the baseline and 1
year scans to the K&L OA grade and total WOMAC scores.
Methods: The 150 subjects were from OAI Progression sub-
cohort public use datasets 0.B.1 and 1.B.1. Their target knees’
sagittal 3D DESS WE sequence (baseline, 1YR) and total WOMAC
scores and K&L grades were used. The images were segmented
using an automated, atlas-based method into bones, cartilage and
anatomic regions. Signal intensities for the deep layer of cartilage
and the superﬁcial layer of bone were used to calculate the
contrast at the bone-cartilage interface for medial and lateral tibial
and femoral weight bearing regions. The contrast measurements
were compared to the OA grade and total WOMAC score. We
used regressions models to study the association of the contrast
measurements to the WOMAC and KL scores. Image pairs that
did not pass the QC were excluded from the analysis.
Results: Cartilage-bone signal contrast at the central femur re-
gions were associated to the KL scores (cMF: r=0.40, p<0.001;
cLF: r=0.24, p=0.002). At baseline, the signal contrast correlated
weakly with WOMAC scores in the medial weight bearing area of
femur (cMF: r=0.21, β p=0.007). Figure 1 shows the box plots at
three OA grades of the contrast at the cMF and the cLF (medial,
lateral weight bearing region of femur). Figure 2 right, shows the
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Abstract 125 –Figure 1. Box plots of contrast at three OA grades.
Abstract 125 – Figure 2. Left, Scatter plot of the model vs baseline and 1 yr change in WOMAC.
scatter plot of the baseline WOMAC to the model: WOMAC = cMF
+ cLF + MT + LT + Tr + MJS + LJS.
The change in cLF associated to the change in the total WOMAC
(r=0.26, β p<0.001). Figure 2 left, shows the scatter plot of the
change in WOMAC to the predictive model WomacChange =
BLWOMAC + cMF + TIME (r=0.42, p<0.001). The study, includ-
ing segmentation of 300 individual MRI HR DESS series was
conducted over 43 calendar days.
Conclusions: Baseline central femur cartilage-bone contrast was
associated with WOMAC scores and contrast changes at the cLF
predicted change in WOMAC scores. This correlation is consistent
with published data describing tidemark vascularization, collagen
breakdown, and inﬂammation, which increase water content, and
affect MRI signal. Although the sample size (n=150) was sig-
niﬁcant, it is still small with regard to the number of individual
measurements derivable from segmented MRI data, and the pop-
ulation sizes stratiﬁed by gender and baseline OA grade. However,
this study indicates that new potential biomarkers’ relation to the
clinical symptoms can be tested in a reasonable time frame in
large data sets.
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Purpose: Arthropathy occurs in approximately 20-30% of patients
with hereditary hemochromatosis (HH). A direct pathogenic role for
cartilage and synovial iron overload has been proposed to explain
joint damage in these patients. The effects of iron depletion by
phlebotomy on cartilage and synovial metabolism and on joint
symptoms have never been speciﬁcally addressed.
The aim of this study was to determine the effects of iron depletion
on serum articular biomarkers levels (Coll2-1, Coll2-1NO2, type
II procollagen (CPII), myeloperoxydase, COMP, and hyaluronan
(HA)) and on articular symptoms in patients with HH.
